{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:50:32Z","timestamp":1769817032297,"version":"3.49.0"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Diagn Lab Immunol"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Single-dose treatment with sodium stibogluconate solution (SSG) and treatment with a nonionic surfactant vesicular formulation of sodium stibogluconate (SSG-NIV) were compared for the ability to protect BALB\/c mice against infection with<jats:italic>Leishmania donovani.<\/jats:italic>Prophylactic treatment with SSG-NIV protected against infection, although its effects were time and organ dependent; protection was not obtained with SSG. Protection against reinfection with<jats:italic>L. donovani<\/jats:italic>was observed only in mice cured by treatment with SSG-NIV. However, this protective effect was probably due to the presence of residual drug rather than an immune effect, since prophylactic SSG-NIV treatment gave similar results. Transfer of enriched spleen T-cell populations from<jats:italic>L. donovani<\/jats:italic>-infected mice or from infected SSG-NIV-treated mice gave no protection against<jats:italic>L. donovani<\/jats:italic>infection in the recipients. T cells from infected mice, but not from infected SSG-NIV-treated mice, were infectious to recipients. SSG-NIV treatment was equally effective against visceral leishmaniasis in immunocompetent and SCID mice, whereas SSG treatment was less effective in the latter. The results of this study suggest that the high antileishmanial activity of SSG-NIV is due to favorable modification of SSG delivery and does not require a fully functional immune response. Cure of visceral leishmaniasis by SSG-NIV treatment in the BALB\/c mouse did not protect against reinfection.<\/jats:p>","DOI":"10.1128\/cdli.6.1.61-65.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T19:21:53Z","timestamp":1577820113000},"page":"61-65","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["The Cured Immune Phenotype Achieved by Treatment of Visceral Leishmaniasis in the BALB\/c Mouse with a Nonionic Surfactant Vesicular Formulation of Sodium Stibogluconate Does Not Protect against Reinfection"],"prefix":"10.1128","volume":"6","author":[{"given":"K. C.","family":"Carter","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Immunology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Baillie","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Pharmaceutical Sciences,2 University of Strathclyde, Glasgow G4 ONR, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Mullen","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Immunology1 and"},{"name":"<!--label omitted: 2-->Pharmaceutical Sciences,2 University of Strathclyde, Glasgow G4 ONR, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-4758(94)90270-4"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(97)00009-X"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/24.4.684"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000051702"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-70740-7_15","article-title":"Response of BALB\/c mice to leishmanial infection.","volume":"122","author":"Blackwell J. M.","year":"1985","unstructured":"Blackwell J. M. Roberts M. B. Alexander J. Response of BALB\/c mice to leishmanial infection. Curr. Top. Microbiol. 122 1985 97 106","journal-title":"Curr. Top. Microbiol."},{"key":"e_1_3_2_7_2","unstructured":"Blackwell J. M. Protozoan infections Genetics of resistance to bacterial and parasitic infection. Wakelin D. Blackwell J. M. 1988 103 151 Taylor and Francis London United Kingdom"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/250353a0"},{"key":"e_1_3_2_9_2","first-page":"119","article-title":"Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infections in mice.","volume":"30","author":"Bradley D. J.","year":"1977","unstructured":"Bradley D. J. Kirkley J. Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infections in mice. Clin. Exp. Immunol. 30 1977 119 129","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1988.tb05271.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190432"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1989.tb06399.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(88)90267-2"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(82)90029-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/10611869308996069"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06526.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.51.2.704-706.1986"},{"key":"e_1_3_2_18_2","unstructured":"Gregoriadis G. Allison A. C. Liposomes in biological systems. 1980 Wiley New York N.Y"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.10.2089"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.54.2.487-493.1986"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.4049\/jimmunol.138.7.2290","article-title":"Experimental visceral leishmaniasis: production of interleukin-2 and interferon-\u03b3, tissue immune reaction, and response to treatment with interleukin-2 and interferon-\u03b3.","volume":"138","author":"Murray H. W.","year":"1987","unstructured":"Murray H. W. Stern J. J. Welte K. Rubin B. Y. Carriero S. M. Nathan C. F. Experimental visceral leishmaniasis: production of interleukin-2 and interferon-\u03b3, tissue immune reaction, and response to treatment with interleukin-2 and interferon-\u03b3. J. Immunol. 138 1987 2290 2297","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","first-page":"127","article-title":"Cytokines in the treatment of leishmaniases.","volume":"1","author":"Murray H. W.","year":"1994","unstructured":"Murray H. W. Cytokines in the treatment of leishmaniases. Baillieres Clin. Infect. Dis. 1 1994 127 143","journal-title":"Baillieres Clin. Infect. Dis."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89503-4"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90476-X"},{"key":"e_1_3_2_25_2","unstructured":"Sacks D. L. Louis J. Wirth D. F. Leishmaniasis Immunology and molecular biology of parasitic infections. Warren K. S. 1993 237 268 Blackwell Scientific Oxford United Kingdom"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.140.11.3971","article-title":"Role of L3T4+ and Ly2+ cells in experimental visceral leishmaniasis.","volume":"140","author":"Stern J. J.","year":"1988","unstructured":"Stern J. J. Oca M. J. Rubin B. Y. Anderson S. L. Murray H. W. Role of L3T4+ and Ly2+ cells in experimental visceral leishmaniasis. J. Immunol. 140 1988 3971","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(79)90037-8"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/10611869509015926"}],"container-title":["Clinical Diagnostic Laboratory Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.6.1.61-65.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.6.1.61-65.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:17:47Z","timestamp":1695568667000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.6.1.61-65.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1128\/CDLI.6.1.61-65.1999"],"URL":"https:\/\/doi.org\/10.1128\/cdli.6.1.61-65.1999","relation":{},"ISSN":["1071-412X","1098-6588"],"issn-type":[{"value":"1071-412X","type":"print"},{"value":"1098-6588","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]},"assertion":[{"value":"1998-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-10-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}